Royce & Associates’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.5M | Sell |
770,451
-384,780
| -33% | -$5.24M | 0.11% | 275 |
|
2025
Q1 | $6.28M | Buy |
1,155,231
+39,240
| +4% | +$213K | 0.07% | 399 |
|
2024
Q4 | $5.52M | Buy |
1,115,991
+214,950
| +24% | +$1.06M | 0.05% | 458 |
|
2024
Q3 | $4.72M | Buy |
901,041
+114,710
| +15% | +$601K | 0.04% | 487 |
|
2024
Q2 | $5.39M | Sell |
786,331
-15,264
| -2% | -$105K | 0.05% | 461 |
|
2024
Q1 | $8.24M | Sell |
801,595
-31,031
| -4% | -$319K | 0.07% | 380 |
|
2023
Q4 | $6.9M | Sell |
832,626
-263,882
| -24% | -$2.19M | 0.06% | 421 |
|
2023
Q3 | $6.85M | Buy |
1,096,508
+76,426
| +7% | +$478K | 0.07% | 399 |
|
2023
Q2 | $4.44M | Sell |
1,020,082
-50,000
| -5% | -$218K | 0.04% | 520 |
|
2023
Q1 | $1.82M | Buy |
1,070,082
+91,306
| +9% | +$155K | 0.02% | 671 |
|
2022
Q4 | $1.9M | Buy |
978,776
+126,232
| +15% | +$245K | 0.02% | 656 |
|
2022
Q3 | $1.68M | Buy |
852,544
+260,058
| +44% | +$512K | 0.02% | 653 |
|
2022
Q2 | $1.21M | Buy |
+592,486
| New | +$1.21M | 0.01% | 728 |
|